Status:

RECRUITING

Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion

Lead Sponsor:

Cairo University

Conditions:

Critically Ill

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Increased days of MV are not without hazards, including barotraumas and ventilator-associated pneumonia. Similarly, premature separation of MV is associated with increased mortality secondary to adver...

Detailed Description

Researchers aim to evaluate the influence of adding parasternal thickening fraction to the standard weaning criteria and its impact on reintubation

Eligibility Criteria

Inclusion

  • critically ill patient mechanically ventilated for 24 hours or more first spontaneous breathing trial

Exclusion

  • patient refusal difficult ultrasound views tracheostomized patient neuromuscular disorders

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT07143695

Start Date

September 1 2025

End Date

August 31 2026

Last Update

September 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cairo University

Cairo, Giza Governorate, Egypt, 6890

Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion | DecenTrialz